• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝硬化患者小肠动力障碍与高胰高血糖素血症有关吗?]

[Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].

作者信息

Chesta J, Generini G, Antezana C, Defilippi C

机构信息

Centro de Gastroenterologia, Hospital Clinico, Universidad de Chile.

出版信息

Rev Med Chil. 1992 Sep;120(9):998-1002.

PMID:1340993
Abstract

Patients with liver cirrhosis develop marked abnormalities in small bowel motility and high plasma glucagon levels. Disturbances in small intestinal motor activity could be related to hyperglucagonemia. To investigate the relationship between fasting plasma glucagon levels and changes in small bowel motility in patients with liver cirrhosis, eighteen cirrhotic patients and ten controls were studied. Plasma glucagon was measured by RIA. Mouth to cecum transit time was estimated by lactulose hydrogen breath test. Fasting small bowel motility was investigated by means of intraluminal manometry. Plasma glucagon levels were significantly higher in patients with cirrhosis (61 +/- 5 pmol/l) than in controls (32 +/- 3 pmol/l); p < 0.01. In patients with liver disease, plasma glucagon levels were not significantly correlated to mouth to cecum transit time (r: -0.32), duration of migrating motor complex (r: -0.24), nor to the frequency of multiple clustered contractions (r: -0.26). The degree of small bowel dysmotility is not related to plasma glucagon levels in patients with hepatic cirrhosis. These results do not support the hypothesis that hyperglucagonemia plays an important pathogenic role in the abnormalities of gut motility in cirrhosis.

摘要

肝硬化患者小肠运动出现明显异常,且血浆胰高血糖素水平升高。小肠运动活动紊乱可能与高胰高血糖素血症有关。为研究肝硬化患者空腹血浆胰高血糖素水平与小肠运动变化之间的关系,对18例肝硬化患者和10例对照者进行了研究。采用放射免疫分析法测定血浆胰高血糖素。通过乳果糖氢呼气试验估算口至盲肠转运时间。通过腔内测压法研究空腹小肠运动。肝硬化患者的血浆胰高血糖素水平(61±5 pmol/l)显著高于对照组(32±3 pmol/l);p<0.01。在肝病患者中,血浆胰高血糖素水平与口至盲肠转运时间(r:-0.32)、移行性运动复合波持续时间(r:-0.24)以及多发成簇收缩频率(r:-0.26)均无显著相关性。肝硬化患者小肠运动障碍程度与血浆胰高血糖素水平无关。这些结果不支持高胰高血糖素血症在肝硬化患者肠道运动异常中起重要致病作用这一假说。

相似文献

1
[Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].[肝硬化患者小肠动力障碍与高胰高血糖素血症有关吗?]
Rev Med Chil. 1992 Sep;120(9):998-1002.
2
Small bowel motility in primary biliary cirrhosis.原发性胆汁性肝硬化中的小肠动力
Am J Gastroenterol. 1998 Dec;93(12):2436-40. doi: 10.1111/j.1572-0241.1998.00700.x.
3
Abnormalities in proximal small bowel motility in patients with cirrhosis.肝硬化患者近端小肠动力异常。
Hepatology. 1993 May;17(5):828-32.
4
[Effects of casein on small intestine motility in patients with liver cirrhosis].
Rev Med Chil. 1996 Feb;124(2):171-7.
5
[Endogenous ethanol production in patients with liver cirrhosis, motor alteration and bacterial overgrowth].[肝硬化、运动改变和细菌过度生长患者的内源性乙醇生成]
Rev Med Chil. 2002 Dec;130(12):1329-34.
6
Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients.
Am J Gastroenterol. 1997 Jun;92(6):1044-5.
7
Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension.肝硬化和门静脉高压患者的小肠动力障碍与细菌过度生长
Am J Gastroenterol. 2003 Jun;98(6):1362-70. doi: 10.1111/j.1572-0241.2003.07475.x.
8
Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.西沙必利与抗生素对肝硬化的长期治疗作用:对小肠动力、细菌过度生长及肝功能的影响
Am J Gastroenterol. 2001 Apr;96(4):1251-5. doi: 10.1111/j.1572-0241.2001.03636.x.
9
[Morphology of the myenteric plexus of the small intestine in patients with liver cirrhosis].[肝硬化患者小肠肌间神经丛的形态学]
Rev Med Chil. 1993 Feb;121(2):139-43.
10
Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.与代偿期肝硬化患者和健康对照组相比,失代偿期肝硬化患者的肠道转运时间较慢。
J Clin Gastroenterol. 2013 Nov-Dec;47(10):888-93. doi: 10.1097/MCG.0b013e31829006bb.

引用本文的文献

1
Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis.奥曲肽对门静脉高压和肝纤维化清醒大鼠肠道转运及细菌移位的影响。
Dig Dis Sci. 2001 Nov;46(11):2367-73. doi: 10.1023/a:1012395013396.
2
Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.肝硬化患者小肠动力改变取决于肝脏疾病的严重程度。
Dig Dis Sci. 1997 Apr;42(4):738-42. doi: 10.1023/a:1018899611006.